Navigation Links
TeamStaff Reports Fourth Quarter and Fiscal 2007 Results; Posts Fourth Quarter Income From Operations
Date:1/15/2008

SOMERSET, N.J., Jan. 15 /PRNewswire-FirstCall/ -- TeamStaff, Inc. (Nasdaq: TSTF), a national provider of healthcare and administrative staffing services, today announced its financial results for the quarter ended September 30, 2007. TeamStaff's revenues from continuing operations for the three months ended September 30, 2007 were $16.5 million as compared to $ 17.4 million in the comparable quarter last year. Income from operations for the three months ended September 30, 2007 was $0.04 million as compared to a loss of $0.58 million in the comparable quarter last year. This represents an improvement of $0.6 million over the prior year. Loss from continuing operations was $.374 million or ($.02) per share compared to $17.2 million or ($.89) per share in the comparable quarter last year. The current quarter results include approximately $0.4 million or ($0.02) per share in legal expense resulting from the government investigation related to pre-acquisition activity in our RS Staffing Services subsidiary. Fourth quarter 2006 included a deferred tax valuation allowance of $16.9 million or ($0.87) per share.

Commenting on the Company's initiatives and performance, TeamStaff's President and CEO, Rick J Filippelli, stated, "We continue to execute on our plan as evidenced by our return to operating profitability in the fourth quarter of fiscal 2007. Over the last three quarters gross margins have improved 300 basis points, SG&A costs have decreased 11% despite almost doubling our sales and marketing expenses and we implemented a new front end system which is expected to improve our operating efficiency. Additionally, we have continued to build and strengthen our management team. In March we hired Terry Merlin who has twelve years of medic
'/>"/>

SOURCE TeamStaff, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. TeamStaff Receives Nasdaq Determination Letter
2. TeamStaff Receives A Letter of Reprimand From Nasdaq; No Further Action Contemplated
3. Health care reform and 2008 elections: New reports examine candidates plans, publics views
4. Consumer Reports Health News
5. CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
6. FDA Reports New Risks Posed by Anemia Drugs
7. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
8. UCI Medical Affiliates, Inc. Reports Fiscal Year End Results for September 30, 2007
9. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
10. HealthPartners Reports 2007 Most Cost Effective Programs Reduce Expenses by $74 Million
11. Par Pharmaceutical Reports Third-Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...heoretical ,anti-cloak, could bring objects out of...ews) -- Just in case someone develops a cloak of i... know how to uncloak the objects it hides. , Ac...certain materials underneath an invisibility cloak..., Researchers at Shanghai Jiao Tong University i...
(Date:9/5/2008).... 5 /PRNewswire/ -- Arthrosurface, Inc.,( http://w...sive joint,resurfacing systems, announced that it ...ts pivotal investigation for its line of focal kne... are no outstanding safety,concerns" with the devi...ce has been evaluating the safety and efficacy of ...
(Date:9/5/2008)...ept. 5 /PRNewswire/ -- Tonight is a momentous,occa...tainment industry,executives, celebrities and prom...acy join forces to Stand Up to Cancer. This collab...p.m. to 9:00 p.m. ET on the three,networks -- ABC,...o elevate,the discussion about cancer and the need...
(Date:9/5/2008)...ewswire/ -- EthicAd, a nonprofit organization,devo...ucation, announces,the launch of a new FDA Web sit...tand direct-to-consumer (DTC) advertising of presc...scription Drug Advertising," is,hosted by the FDA,...developed by the FDA in partnership with EthicAd. ...
Breaking Medicine News(10 mins):Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:The Leukemia & Lymphoma Society: Standing Up to Cancer for 60 Years 2Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2
...ple with heart disease to travel by air? For the s...idence on // issues involving air travel for heart... security devices on implantable automatic defibri...reening, and the potential for in-flight deep vein...
...focused on depression in elderly people living in ...s or nursing homes found that // depression and it...many elderly people . The study, involved 250 part...At the start of the study, researchers determined ...
...ey may have found a way to diagnose melancholic de...hem to observe // levels of certain substances in...m of depression marked by insomnia, loss of appeti... study show low levels of the inhibitory transmitt...
...roup of diseases that affect the lungs, including ...rized by permanent // lung damage and irreversible...d, the airways become inflamed, causing airflow ob...e to the lungs is not thought to be permanent. Plu...
Other Medicine News:
(Date:9/5/2008)...W.Va., Sept. 5 /PRNewswire-USNewswire/ -- A team o...n that U.S. immigrants from,India and Pakistan tak...ng,their risks of prostate cancer among male immig...ancer and prostate cancer develop due to many reas...a major role in these cancers,",said Jame Abraham,...
(Date:9/4/2008)...alif., Sept. 4 /- BioForm M... the pivotal clinical study of,Polidocanol, conduc...sche,Fabrik KREUSSLER & Co. GmbH (Kreussler), succ...en submitted to FDA as part of a New Drug Applicat..., named the EASI (Efficacy and safety of,Aethoxysk...
(Date:9/4/2008)...Ala., Sept. 4 /- Southern Research In...es of Health (NIH) has selected,the organization t...ies,Probe Production Center Network (MLPCN). The M...t of the Molecular Libraries Program which is,desi...nowledge of the human,genome and validate future t...
(Date:9/4/2008)...demonstrates potent antiviral activity and favorab... CAMBRIDGE, Mass., Sept. 4 /PRNewswire-FirstCall/... a biopharmaceutical company engaged,in the discov...human viral,and other infectious diseases, today a...t study evaluating IDX899, a non-nucleoside revers...
Breaking Medicine Technology:Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Six Finalists Announced for 2008 Insight Award for Customer Advocacy in Financial Services 14164 1ESFs European ice core project EPICA receives prestigious Descartes Prize 2477 1ESFs European ice core project EPICA receives prestigious Descartes Prize 2477 2ESFs European ice core project EPICA receives prestigious Descartes Prize 2477 3Gene Hunters Fine Tune Marker for Common Obesity Gene 1509 1Gene Hunters Fine Tune Marker for Common Obesity Gene 1509 2Gene Hunters Fine Tune Marker for Common Obesity Gene 1509 3Caring com Joins Entrepreneurs Foundation as 200th Member 14153 1Caring com Joins Entrepreneurs Foundation as 200th Member 14153 2
...une 14, 2007 /PRNewswire-FirstCall/ Haemacure,Corp...cs company,today announced the preliminary findin...scards. , Preliminary findings confirm the presenc...tions in significant worldwide,markets, including ...hese findings take on a strategic significance for...
...(BUSINESS WIRE)--Jun 15, 2007 - Next Safety,Inc. ...omise to,revolutionize pulmonary drug delivery. Th...d air to deliver medications deep into the,pulmona... delivery,systems because it rapidly administers a...viously unrealized efficiencies. The,delivery tech...
Other Medicine Technology:Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 2Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 3Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 4Next Safety, Inc.'s Innovative Drug Delivery System Will Replace,Cigarettes and Significantly Advance Pulmonary Medication Delivery 2
100cc silicone evacuator with hubless flat drain and trocar
Used following open gallbladder procedure to drain bile. Often attached to Bard bile bag.
Silicone Flat Hubless Drains
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Medicine Products: